Neil Morton McKern

Title: Neil Morton McKern: Innovator in EGF Receptor Research

Introduction

Neil Morton McKern is a notable inventor hailing from Lilydale, Australia. He has made significant contributions in the field of biomedical research, specifically relating to receptor molecules that play crucial roles in various biological processes.

Latest Patents

McKern holds a patent for a truncated epidermal growth factor (EGF) receptor. This invention involves truncated EGF receptor molecules that demonstrate increased binding affinities for EGF ligands, such as EGF and TGF-α. The patent further covers methods for screening EGF receptor ligands and treatment methodologies utilizing these innovative molecules.

Career Highlights

Throughout his career, McKern has been associated with prominent organizations such as the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the Ludwig Institute for Cancer Research Limited. His work at these institutions has been instrumental in advancing our understanding of cancer biology and receptor interactions.

Collaborations

During his professional journey, Neil has collaborated with esteemed colleagues, including Colin Wesley Ward and George Oscar Lovrecz. Their collective efforts have contributed to significant advancements in the field and the successful development of innovative research projects.

Conclusion

Neil Morton McKern's inventive work and dedication to research continue to impact scientific fields related to EGF receptors. His patents and collaborations highlight the importance of innovation in medical research, particularly in developing treatments that could change the landscape of cancer therapy.